Follicular meiosis-activating sterol

Drug Profile

Follicular meiosis-activating sterol

Alternative Names: FF-MAS

Latest Information Update: 16 Jul 2016

Price : $50

At a glance

  • Originator Nonindustrial source; Novo Nordisk; Rigshospitalet
  • Developer Nonindustrial source; Novo Nordisk
  • Class
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Female infertility

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Female-infertility in Denmark
  • 24 Mar 2000 New profile
  • 24 Mar 2000 Preclinical development for Female infertility in Denmark (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top